Drugmaker Regeneron Pharmaceuticals says this will seemingly adjust to privacy insurance policies relating to the utilization of buyer records. 23andMe’s financial catastrophe filings had drawn scrutiny from lawmakers who warned that thousands and thousands of customers’ genetic records can also fair be sold to unscrupulous investors…
Read Extra
2025-05-20
